vTv Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

vTv Therapeutics

09/11/2021 15:00

* vTv Therapeutics Inc  VTVT.OQ  reported a quarterly adjusted
loss of 2 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 7 cents per share.
* Revenue rose 42,757.1% to $3.00 million from a year ago; 
analysts expected $1.30 million. 
* vTv Therapeutics Inc's reported EPS for the quarter was a loss
of 2 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* vTv Therapeutics Inc shares had fallen by 2.0% this
quarter and lost 19.4% so far this year.
* The company reported a quarterly loss of $1.09 million.
* Wall Street's median 12-month price target for vTv
Therapeutics Inc is $6.75 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 03:00 p.m.
 ​All figures in US dollars unless otherwise stated